The DIM ITAC gathers more than forty partners from Ile-de-France region: academic and industrial laboratories belonging to thirteen supervisory authorities, biotechnology companies, competitiveness clusters. The scientific excellence of each entity, as well as the complementarity between the members, are the assets that will allow the DIM ITAC to achieve its objective.
The Ile-de-France Region represents a high-level hub for fundamental, translational and clinical research in immunotherapy. It’s also the leading region in Europe and one of the first in the world, in terms of clinical trials. The coexistence of highly specialized fundamental research units and leading translational and clinical research teams constitutes the basis to develop a competitive field of research and innovation in immunotherapies around cancer and autoimmunity, nationally and internationally.
DIM ITAC gathers :
